---
title: Splenic iron decreases without change in volume or liver parameters during
  luspatercept therapy
date: '2023-09-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37704579/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20230914180826&v=2.17.9.post6+86293ac
source: Blood
description: 'Splenic iron decreased while liver iron was stable during luspatercept
  therapy in some thalassemic individuals. This suggests reduction of ineffective
  erythropoiesis changes organ distribution of iron and demonstrates that liver iron
  concentration alone may not accurately reflect total body iron. Clinical trials:
  BEYOND: NCT03342404; BELIEVE: ...'
disable_comments: true
---
Splenic iron decreased while liver iron was stable during luspatercept therapy in some thalassemic individuals. This suggests reduction of ineffective erythropoiesis changes organ distribution of iron and demonstrates that liver iron concentration alone may not accurately reflect total body iron. Clinical trials: BEYOND: NCT03342404; BELIEVE: ...